1.
Controlling arachidonic acid metabolic network: from single-to multi-target inhibitors of key enzymes
花生四烯酸代谢网络研究:从关键酶的单靶标抑制剂到多靶标抑制剂
2.
Studies on Design, Synthesis and Properties of Inhibitors of the Target Enzyme;
靶标酶抑制剂的设计、合成与性质研究
3.
The Rational Design and Theoretical Study Based on FBPase and SBPase Inhibitors
以FBPase和SBPase为靶标的抑制剂设计和理论研究
4.
Studies on the Screening of Phytopathogenic Fungal Inhibitors Using Glucan Synthase as a Target;
以葡聚糖合酶为靶标筛选植物病原真菌抑制剂的研究
5.
Investigation of the Target Genes Involved in Tumor Cell Apoptosis Induced by HDAC Inhibitor
HDAC抑制剂抗肿瘤效应靶基因的研究
6.
Preliminary Study on the Susceptibility of Herbicide-targeted Acetolactate Synthase to Inhibitors and Its Molecular Mechanism;
除草剂靶标乙酰乳酸合成酶对抑制剂敏感性及其分子机理的初步研究
7.
a monoamine oxidase inhibitor (trade name Marplan) that is used to treat clinical depression.
用来治疗临床抑郁症的一种单胺氧化酶抑制剂（商标是Marplan）。
8.
Studies on a Series of Porphyrin Complexes Targeting G-Quadruplex DNA
以G4-DNA为靶点的卟啉类端粒酶抑制剂的研究
9.
RhoA/Rho kinase:a potential new target for drug therapy in asthma and development of inhibitors
哮喘治疗新靶点——RhoA/Rho激酶及其抑制剂开发
10.
LEDGF/p75:a novel target for anti-HIV therapy and advances in the study of its related inhibitors
LEDGF/p75:抗HIV-1感染的新靶点及其抑制剂研究
11.
Progress in Sodium-glucose Co-transporter-2 Inhibitors:the New Target for Treatment of Type 2 Diabetes
2型糖尿病治疗新靶点SGLT2抑制剂的研究进展
12.
Multi-targeted protein tyrosine kinase inhibitor:research advances
多靶点蛋白酪氨酸激酶抑制剂的研究进展
13.
Advances in the research of multi-target tyrosine kinase inhibitors
多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
14.
Progress on the new Alzheimer's disease therapy target-cylin-dependent kinase-5 and its inhibitors
Alzheimer病治疗新靶点Cdk5及其抑制剂的研究进展
15.
Progress in research of multi-targeted inhibitors of receptor tyrosine kinase
多靶点受体酪氨酸激酶抑制剂的研究进展
16.
Screening for Bacterial Quorum Sensing Inhibitors
以细菌群体感应为靶标的抑制因子筛选
17.
Study on the Inhibitory effects of Yunnan province tea germplasms on PTPs targets
云南省茶树资源对PTPs靶标的抑制效果研究
18.
Mechanism of drug resistance for chronic myeloid leukemia to BCR-ABL tyrosine kinase inhibitor
慢性粒细胞白血病对BCR-ABL酪氨酸激酶靶向抑制剂的耐药机制